Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery
China-Japan Friendship Hospital
120 participants
Feb 1, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to investigate the effects of Chinese herbal granule preparations on improving gastrointestinal symptoms in patients after bariatric surgery. It seeks to establish a novel treatment model that combines bariatric surgery with traditional Chinese medicine, providing clinical practice with additional evidence-based medical support.
Eligibility
Inclusion Criteria3
- BMI ≥ 27.5 kg/m²;
- Undergoing metabolic bariatric surgery;
- Traditional Chinese Medicine syndrome differentiation classified as Spleen Deficiency and Excess Dampness syndrome.
Exclusion Criteria5
- Contraindications for metabolic bariatric surgery;
- Type 1 diabetes;
- Complicated by other significant systemic diseases, such as severe liver and kidney diseases, malignant tumors, psychiatric disorders, etc;
- Concurrent use of other medications or treatments that may affect body weight, such as metformin, semaglutide, endoscopic interventions, etc;
- Pregnant or lactating women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Composition: Raw Astragalus (Huang Qi) 5g, Cang Zhu 5g, Fructus Aurantii Immaturus (Zhi Shi) 3g, Prepared Rhubarb (Shu Jun) 3g, Red Peony Root (Chi Shao Yao) 3g, Crataegus (Shan Zha) 3g, Tribulus (Bai Jie Li) 2g, Cimicifuga (Sheng Ma) 1g. Granule form, for oral administration. Take 1 dose daily (2 bags, once in the morning and once in the evening, dissolved in water), for a course of 1 month.
The dietitian provides recommended meal plans based on body weight, and meal replacements are used postoperatively.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06419764